NCT03901846View on ClinicalTrials.gov

Duration of ColdZyme® II

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

May 7, 2019

Primary Completion Date

July 25, 2019

Study Completion Date

July 25, 2019

Conditions
Common Cold
Interventions
DEVICE

ColdZyme

ColdZyme is a Class I medical device (CE-marked) with the following composition: glycerol, water, Tris buffer, CaCl2, menthol and trypsin

Trial Locations (1)

Unknown

Cutis Clinical Research Center, Kopavogur

Sponsors

Lead Sponsor

Enzymatica AB
All Listed Sponsors
lead

Enzymatica AB

INDUSTRY